PIPZEC 4.5.

Description

• First line option in moderate to severe bacterial infections
• Highly useful in the treatment of patients with polymicrobial infections caused by aerobic or anaerobic Beta- Lactamase producing bacteria
• Increases initial treatment success, thereby reducing hospital stay & the use of additional anti-bacterials